A triple hormone receptor agonist activates three metabolic pathways, typically targeting GLP-1, GIP, and glucagon receptors. It is used to improve blood sugar control, enhance weight loss, and reduce cardiovascular risk. This therapy primarily benefits individuals with type 2 diabetes or obesity who need a comprehensive approach to managing multiple metabolic conditions.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends